Bio Essence Corp

Capital Structure and Liquidity Bio Essence Corp has a negative total equity of $2,072,890 and a debt-to-equity ratio of -0.03, indicating a capital structure heavily reliant on liabilities. The company's current ratio of 0.17 suggests significant liquidity constraints, as current assets are insufficient to cover current liabilities. Despite this, the company generates strong operating cash flow of $1,569,750 and free cash flow of $896,440, which could support near-term obligations. ### Profitability and Returns The company's return on assets (ROA) of 2.12% is positive, indicating that it is generating returns on its asset base. However, the return on equity (ROE) is negative at -43.23%, reflecting the negative equity position and the impact of financial leverage. These metrics suggest that while the company is asset-efficient, it is not effectively generating returns for shareholders due to its capital structure. ### Segments and Geographic Exposure Bio Essence Corp operates in the herbal health, diet, and nutrition space, with a primary focus on health supplements and OEM services. The company does not disclose specific geographic revenue concentrations, but its business model suggests a potential reliance on domestic markets given the nature of its operations. ### Growth Trajectory The company reported revenue of $1,897,570 in the latest period. While the outlook for the current and next fiscal years is not explicitly provided, the strong operating cash flow and free cash flow suggest potential for growth if the company can address its liquidity and equity challenges. ### Risk Factors The company faces medium liquidity risk due to its current ratio of 0.17 and negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure from share issuance or other dilutive events. The negative equity position and reliance on liabilities pose a significant financial risk, particularly if the company's cash flow generation is disrupted. ### Recent Events No specific recent events such as filings or transcripts are provided in the input data to inform the company's recent developments.